Shanghai Fosun Pharmaceutical Group Co., Ltd. (08HH)
XSTU
1.82
-0.06 (-3.33%)
Closed
Aug 24, 2026
Day's Range
1.811.82
52 wk Range
1.663.09
Financial Statements - 08HH - Shanghai Fosun Pharmaceutical Group Co., Ltd.
Revenue
41.66B▲ 1.4%
Net Income
4.24B▲ 20.9%Net Margin 10.2%
EBITDA
10.41B▲ 21.8%
Free Cash Flow
764.77M▲ 1045.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 41.66B | 41.06B | 41.39B | 43.95B | 39.01B | 30.30B |
| Cost of Goods | 20.80B | 21.36B | 21.59B | 23.16B | 20.22B | 13.73B |
| Gross Profit | 20.86B | 19.70B | 19.80B | 20.78B | 18.78B | 16.57B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 3.14B | 3.20B | 1.56B | 3.63B | 2.70B | 2.83B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 5.11B | 4.16B | 3.26B | 4.57B | 6.04B | 4.67B |
| Income Tax | 864.05M | 656.84M | 369.50M | 626.91M | 1.06B | 737.86M |
| Net Income | 4.24B | 3.51B | 2.89B | 3.94B | 4.97B | 3.93B |
| EPS Basic | 1.27 | 1.04 | 0.89 | 1.43 | 1.85 | 1.43 |
| EPS Diluted | 1.27 | 1.04 | 0.89 | 1.43 | 1.85 | 1.43 |
| Basic Shares Outstanding | 2.65B | 2.66B | 20.97B | 19.72B | 19.32B | 19.36B |
| Diluted Shares Outstanding | 2.65B | 2.66B | 20.97B | 19.72B | 19.32B | 19.36B |
| Ebit | 6.37B | 5.60B | 4.58B | 5.53B | 6.86B | 5.55B |
| Ebitda | 10.41B | 8.55B | 8.32B | 10.58B | 9.26B | 6.89B |
| Net Income Continuous Operations | 4.24B | 3.51B | 2.89B | 3.94B | 4.97B | 3.93B |
| Minority Interests | -877.36M | -742.55M | -508.79M | -216.65M | -247.55M | -277.16M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
